等待開盤 08-07 09:30:00 美东时间
+0.030
+0.06%
8 月 4 日,ClinicalTrials.gov 官网显示,诺华(NVS.US)登记了一项英克司兰钠的 III 期临床,旨在评估急性冠状动脉综合征(ACS)患者住院早期开始英克司兰钠治疗的疗效和安全性。
08-05 20:57
Carlsmed, Inc. ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule (IPPS) for
08-01 21:07